Workflow
K - Beauty
icon
Search documents
Kolmar Korea Presents "K-Beauty Success Roadmap" in Amazon Beauty in Seoul
Prnewswire· 2025-10-01 14:07
Core Insights - Kolmar Korea collaborates with Amazon to create a strategic roadmap for the global expansion of K-Beauty, emphasizing technological expertise as a key competitive advantage [1][5][8] Group 1: Event Overview - Kolmar Korea served as the exclusive manufacturing sponsor for Amazon Beauty in Seoul 2025, which took place on September 19, attracting over 3,000 attendees from the beauty industry [3][7] - The event featured notable speakers, including Sang-Hyun Yoon, Vice Chairman of Kolmar Group, who delivered a keynote address on K-Beauty's success from a manufacturer's perspective [3][4] Group 2: Key Messages from Leadership - Vice Chairman Yoon highlighted the necessity of evolution and innovation for brands to avoid obsolescence, stressing that the competitive nature of the Korean market has laid the foundation for K-Beauty's global success [4][5] - Yoon also pointed out that understanding consumer needs and expanding product offerings are crucial for achieving international success [4] Group 3: Company Initiatives - Kolmar Korea showcased a variety of solutions in skincare, makeup, personal care, sun care, and cosmetic packaging at the event, providing tailored consultations to potential business partners [4][5] - The company aims to support clients' global market expansion through its ongoing partnership with Amazon, reinforcing the importance of ODM companies in the sustainable growth of K-Beauty [5][6] Group 4: Company Background - Founded in 1990, Kolmar Korea is a leader in the cosmetics, pharmaceuticals, and health supplements sectors, specializing in ODM solutions and offering end-to-end services from formulation to finished product [6]
Hugel hosts global H.E.L.F. symposium, marking 15 years of botulinum toxin Letybo
Prnewswire· 2025-09-15 00:30
Core Insights - Hugel Inc. hosted its global medical symposium H.E.L.F. in Seoul to celebrate the 15th anniversary of its botulinum toxin product Letybo, attracting around 220 professionals from over 25 countries, marking the highest representation at a Hugel event [1][3]. Group 1: Event Overview - The H.E.L.F. symposium has been a flagship event for Hugel since 2013, focusing on sharing insights and clinical techniques in medical aesthetics [2]. - The event featured 10 lectures and discussions across three sessions, covering topics such as botulinum toxin, hyaluronic acid filler, and absorbable suture [4]. Group 2: Session Highlights - The first session addressed personalized aesthetics and adapting Korean medical aesthetics to global markets, featuring speakers from various clinics [5]. - The second session focused on facial contouring techniques, with contributions from renowned surgeons in the aesthetic medicine field [6]. - The third session presented the latest clinical cases and strategies using Letybo, concluding with a panel discussion [6]. Group 3: Company Positioning - Hugel aims to drive the K-Beauty movement by providing integrated solutions in medical aesthetics, emphasizing its commitment to advancing the industry through academic initiatives and knowledge exchange [7]. - Established in 2001, Hugel specializes in injectables for skin rejuvenation and is a market leader in South Korea, with regulatory approvals in the US, China, and Europe [8]. - The company has expanded its presence to approximately 70 countries and operates nine global subsidiaries, positioning itself for continued growth and market expansion [8].
虚假纳税申报,这家微整形护肤护肤品牌被罚近620万
Sou Hu Cai Jing· 2025-08-15 02:13
编辑/李彦 8月11日,巴西美妆集团Natura&Co发布2025年第二季度财报,营收为56.87亿雷亚尔(约合人民币75.13亿元),同比基本持平;经常性EBITDA为7.96亿雷 亚尔(约10.51亿元),利润率14.0%;净利润达1.95亿雷亚尔(约2.58亿元),相比去年同期净亏损8.59亿雷亚尔(约11.35亿元)显著改善。 公司表示,整体稳健表现主要得益于Natura品牌的增长,巴西市场销售额同比增长10.3%,西班牙裔国家市场增长17.8%。雅芳品牌在巴西市场依旧疲软,在 西班牙裔国家的业绩也因整合影响而波动。 报告期内,Natura&Co继续推进精简战略,包括实施雅芳国际的战略替代方案,并将雅芳中美洲及多米尼加业务(CARD)重新归类为待售资产;同时, Natura&Co与Natura Cosméticos S.A.完成合并,控股公司架构进一步简化。 毛戈平上半年营收预计增长逾三成 8月12日,"国货高端美妆第一股"毛戈平发布业绩预告,预计2025年上半年收入约25.7亿至26亿元,同比增长30.4%至31.9%;净利润约6.65亿至6.75亿元,同 比增长35%至37%。以2024年上半年营 ...